Aveanna Commences Trading on Nasdaq
Aveanna Healthcare has commenced trading on the Nasdaq Global Select Market under the ticker symbol AVAH. The company completed its initial public offering of 38,236,000 shares at a public price of $12.00 per share, with an additional option for underwriters to purchase up to 5,735,400 shares. This IPO signifies a milestone for Aveanna as it aims to enhance care for patients across the United States. The offering's joint lead managers include Barclays and J.P. Morgan among others.
- Successful IPO with 38,236,000 shares sold at $12.00 each.
- Potential for underwriters to purchase an additional 5,735,400 shares.
- None.
ATLANTA, April 29, 2021 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that its common stock has begun trading on the Nasdaq Global Select Market under the ticker symbol “AVAH.”
Aveanna’s initial public offering consisted of 38,236,000 shares of common stock, at a price to the public of
“This is an exciting milestone for our company as we continue our mission of serving patients across the United States,” said Rod Windley, Chairman of Aveanna. “This is a testament to our dedicated care givers and team members who have ensured the delivery of critical and meaningful care when patients need it most. We now look ahead to a bright future, as we find new and better ways to continue providing patients and their families with the highest quality care.”
Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse are acting as joint lead book-running managers, and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets and Truist Securities are acting as book-running managers for the offering. Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank are acting as co-managers for the offering.
A registration statement on Form S-1 relating to this offering was filed with, and declared effective by, the Securities and Exchange Commission. The offering was made only by means of a prospectus. Copies of the final prospectus related to the offering, when available, may be obtained from:
- Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at barclaysprospectus@broadridge.com or by telephone at 1-888-603-5847;
- J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by email at prospectus-eq_fi@jpmchase.com or by collect telephone at 1-212-834-4533;
- BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036, by email at bmoprospectus@bmo.com or by telephone at (800) 414-3627; or
- Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, United States, by email at usa.prospectus@credit-suisse.com or by telephone at 1-800-221-1037.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Aveanna Healthcare
Based in Atlanta, Georgia, Aveanna is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna directly addresses the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.
Contact
Ross Lovern
Kekst CNC
(917) 842-7205
Ross.lovern@kekstcnc.com
FAQ
What is the ticker symbol for Aveanna Healthcare?
When did Aveanna Healthcare's stock begin trading?
How many shares did Aveanna Healthcare offer in its IPO?
What was the initial offering price for Aveanna Healthcare's shares?
Who were the joint lead managers for Aveanna Healthcare's IPO?
